Skip to main content
Log in

Genetic sequences: how are they patented?

  • Patents
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

A survey reveals that the way in which genetic sequences are claimed in granted patents are heterogeneous and imprecise, which may lead to questions regarding their validity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Grisham, J. Nature 18, 921 (2000).

    CAS  Google Scholar 

  2. Walker, B.W. & Carty, S.M. Nat. Biotechnol. 21, 943 (2003).

    Article  Google Scholar 

  3. See, for example, US Patent No. 6,590,077.

  4. See, for example, US Patent No. 6,586,202.

  5. Caccone, A., DeSalle, R. & Powell, J.R. J. Mol. Evol. 27, 212 (1988).

    Article  CAS  Google Scholar 

  6. Dufresne, G., Takacs, L., Heus, H., Codani, J.J. & Duval, M. Nat. Biotechnol. 20, 1269 (2002).

    Article  CAS  Google Scholar 

  7. See, for example, US Patent No. 6,319,675.

  8. See, for example, US Patent No. 6,589,767.

  9. Doyle, J.J. & Gaut, B.S. Plant Mol. Biol. 42, 1 (2000).

    Article  CAS  Google Scholar 

  10. Durbin, R., Eddy, S., Krogh, A. & Mitchison, G. Biological Sequence Analysis (Cambridge University Press, Cambridge, UK, 1998).

    Book  Google Scholar 

  11. See, for example, EP Patent No. 668,351.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Manuel Duval.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dufresne, G., Duval, M. Genetic sequences: how are they patented?. Nat Biotechnol 22, 231–232 (2004). https://doi.org/10.1038/nbt0204-231

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0204-231

  • Springer Nature America, Inc.

Navigation